£2
No changevs Nov 2024Active09332508Private limited companyBurgess Hill
SENTURION PHARMA LTD
Significant control: William Rhys-Williams (25–50%), Richard George Arthur Faragher (25–50%)
From public filings as at 31 Aug 2026; may contain errors or be out of date. Verify at Companies House · Terms
Coming soon · product and service lists
What does Senturion Pharma Ltd sell?
Registered activity: Research and experimental development on biotechnology (SIC 72110). We’re building product and service lists for UK companies. Get this one when it’s ready.
One email, only about this. If we don’t launch within 60 days we’ll tell you. Privacy
01
Summary
SENTURION PHARMA LTD is an active private limited company (company number 09332508) incorporated on 28 November 2014, registered in Burgess Hill. Its registered activity is research and experimental development on biotechnology (SIC 72110). Latest dormant accounts cover the period ending 30 November 2025, showing net assets of £2. Net assets were unchanged on the prior period.
Peer position · net assets
By net assets it sits in the lower half of 54 comparable companies in Surrey (median £1,000, upper quartile £121k).
02
Ownership and control
- Dr William Rhys-Williams
- owns 25–50% of shares
- Dr. Richard George Arthur Faragher
- owns 25–50% of shares
Persons with significant control hold 25% or more of shares or voting rights. Smaller shareholdings are only listed in confirmation-statement documents. Directors and secretaries: see the officers list at Companies House.
03
Key dates
- Incorporated
- 28 November 201411 yrs ago
- Next accounts due
- 30 August 2027in 311 days
- Confirmation statement due
- 12 December 2026in 50 days
Due dates are expected from Companies House filing rules; confirm on the official register before relying on them.
04
Activity
- SIC 72110
- Research and experimental development on biotechnology
- Accounts type
- Dormant
- Size band
- MicroCompanies Act thresholds
05
Financials
Not reported
Not reported
Not reported
| Period end | Net assets | Cash | Debtors | Creditors <1y | Turnover | Profit | Employees |
|---|---|---|---|---|---|---|---|
| 30 November 2025 | £2 | — | — | — | — | — | — |
| 30 November 2024 | £2 | — | — | — | — | — | — |
Figures as filed in iXBRL accounts at Companies House. "—" means the line was not reported in that filing.
06
Filing and accounts signals
- Net assets above zeroNet assets £2 at 30 November 2025
- Incorporated five or more years agoIncorporated 28 November 2014
Neutral facts read from the register and filed accounts, each with its evidence. They are not a rating, a prediction or advice, and may be incomplete or out of date. How each signal is derived.
07
Timeline
- Next accounts duein 311 days
- Confirmation statement duein 50 days
- Accounts period endNet assets £2 · dormant accounts
- Accounts period endNet assets £2 · dormant accounts
- Incorporated
08
Similar companies in Surrey
- TSP ADVANCED TECHNOLOGIES PLCGatwick · inc. Dec 2014
- TRUSPINE TECHNOLOGIES INTERNATIONAL LIMITEDGatwick · inc. Dec 2014
- NATURE METRICS LTDGuildford · inc. Oct 2014
- GLOBAL ALLIANCE FOR RESEARCH ON AVIAN DISEASES LIMITEDCamberley · inc. Aug 2014
- LIMEWAY PHARMA DESIGN LIMITEDDorking · inc. Mar 2015
- EPSILON BIOCONSULTING LIMITEDHaywards Heath · inc. Jun 2014
All companies incorporated on 28 November 2014 · in Nov 2014.
09
Reminders for SENTURION PHARMA LTD
Get an email before each filing deadline — accounts and confirmation statement — so nothing is late.